All download files including the archive files are now in a publicly accessible Google Storage Bucket. Downloads page links have been updated.

Not found

Our G-nome assistant hasn't been able to find this symbol report. Please check the URL or use our search to find what you are looking for.

Symbol report for NRG4

HGNC data for NRG4

Approved symbol
NRG4
Approved name

neuregulin 4

Locus type
gene with protein product
HGNC ID
HGNC:29862
Symbol status
Approved
Alias symbols
HRG4
Chromosomal location
15q24.2
Gene groups
Equus caballus
NRG4 VGNC:20884 VGNC
Felis catus
NRG4 VGNC:80904 VGNC
Macaca mulatta
NRG4 VGNC:84411 VGNC
Mus musculus
Nrg4 MGI:1933833 Curated
Pan troglodytes
NRG4 VGNC:1904 VGNC
Rattus norvegicus
IUPHAR/BPS Guide to PHARMACOLOGY
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis.
Wang GX et al. Nat Med 2014 Dec;20(12)1436-1443
Wang GX, Zhao XY, Meng ZX, Kern M, Dietrich A, Chen Z, Cozacov Z, Zhou D, Okunade AL, Su X, Li S, Blüher M, Lin JD.
Nat Med 2014 Dec;20(12)1436-1443
Abstract: Brown fat activates uncoupled respiration in response to cold temperature and contributes to systemic metabolic homeostasis. To date, the metabolic action of brown fat has been primarily attributed to its role in fuel oxidation and uncoupling protein 1 (UCP1)-mediated thermogenesis. Whether brown fat engages other tissues through secreted factors remains largely unexplored. Here we show that neuregulin 4 (Nrg4), a member of the epidermal growth factor (EGF) family of extracellular ligands, is highly expressed in adipose tissues, enriched in brown fat and markedly increased during brown adipocyte differentiation. Adipose tissue Nrg4 expression was reduced in rodent and human obesity. Gain- and loss-of-function studies in mice demonstrated that Nrg4 protects against diet-induced insulin resistance and hepatic steatosis through attenuating hepatic lipogenic signaling. Mechanistically, Nrg4 activates ErbB3 and ErbB4 signaling in hepatocytes and negatively regulates de novo lipogenesis mediated by LXR and SREBP1c in a cell-autonomous manner. These results establish Nrg4 as a brown fat-enriched endocrine factor with therapeutic potential for the treatment of obesity-associated disorders, including type 2 diabetes and nonalcoholic fatty liver disease (NAFLD).